Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,382 total articles
PROCEPT BioRobotics highlights the updated American Urological Association (AUA) guidelines strengthening the recommendation for its Aquablation therapy as a surgical option for benign prostatic hyperplasia (BPH). The guidelines now support Aquablation for prostate volumes 30–80 mL and recognize its use in larger prostates (80–150 mL), supported by…
Cingulate Inc. announced its Q1 2026 financial results showcasing a significantly strengthened balance sheet with $25.9 million in cash and an improved working capital position. The company continues to advance commercial readiness for its lead ADHD asset, CTx-1301, leveraging its proprietary Precision Timed Release platform. The NDA for CTx-1301 i…
Apyx Medical Corporation announced the publication of a retrospective clinical study demonstrating that adding their Renuvion helium plasma radiofrequency technology to liposuction significantly improves patient satisfaction with abdominal appearance and excess skin, reduces the need for abdominoplasty and revisions, while maintaining comparable co…
Mobilicom Limited announced its participation in SOF Week 2026, engaging with defense customers and stakeholders to discuss its portfolio of cybersecure autonomous drone and robotics technologies designed for special operations. The company plans to highlight its SkyHopper Tactical platform with FCC Trusted Drone status, aiming to meet evolving ope…
Aureus Greenway Holdings Inc. (Nasdaq: AGH) will change its ticker symbol to PUSA, effective May 15, 2026, aligning with its anticipated merger this summer with Autonomous Power Corporation (Powerus), a leader in autonomous drone and defense technologies. Upon closing, the combined entity will operate as Powerus Corporation, focusing on defense, ho…
IN8bio presented translational data demonstrating that repeated dosing of its genetically modified gamma-delta T cell therapy, DeltEx DRI, preserves immune function, remodels the tumor microenvironment, and correlates with improved survival outcomes in glioblastoma. Advanced analytical methods integrating AI, immunogenomics, and spatial transcripto…
Off The Hook YS Inc., a U.S.-based AI-powered marine marketplace, has completed the acquisition of Apex Marine Companies, enhancing its operational efficiency, refurbishment capabilities, and global sales reach. The acquisition adds key South Florida facilities and skilled teams, enabling in-house servicing and refurbishment of vessels, reducing co…
Clene Inc. announced positive regulatory feedback from the FDA regarding its CNM-Au8 drug candidate for amyotrophic lateral sclerosis (ALS), with plans to submit a New Drug Application (NDA) under the accelerated approval pathway in Q3 2026. The company completed significant financing totaling over $35 million in early 2026, amended debt facilities…
Freshworks Inc. announced the launch of Freddy AI Agent Studio within its Freshservice platform, providing enterprises with a flexible, no-code solution to build and deploy custom AI agents that streamline service operations across IT, HR, finance, and facilities. This innovation aims to address the growing support gap for after-hours IT service by…
Gentherm announced it will showcase its WellSense™ technology at NeoCon 2026, highlighting its expansion into the Home and Office market. Leveraging decades of automotive and medical temperature management innovation, Gentherm is applying science-backed thermal and pneumatic comfort systems to furniture to enhance wellness, focus, relaxation, and r…
CVRx announced that Humana has issued a Medicare Advantage coverage policy for Barostim therapy, effective May 1, 2026. This marks the first coverage policy for Barostim by a major Medicare Advantage provider, covering patients meeting FDA-approved indications and those in the BENEFIT-HF trial. This follows other positive reimbursement developments…
Benitec Biopharma Inc. announced its third quarter 2026 financial results and provided an operational update on BB-301, its gene therapy candidate for Oculopharyngeal Muscular Dystrophy (OPMD). Interim clinical data shows durable and improving responses in patients treated with low and high doses of BB-301, with no severe adverse events. The compan…
Provident Bank released its 2026 Consumer Survey illustrating ongoing financial challenges faced by American households, including inflation, high interest rates, and a stagnant housing market. The survey reveals consumers are prioritizing basic necessities, managing debt more cautiously, and seeking financial guidance, though a gap exists in perce…
Microchip Technology Inc. announced the EX-423 Evacuated Miniature Crystal Oscillator (EMXO), a compact, low-power timing solution designed to offer high stability, accuracy, and long-term reliability. The device targets applications demanding ruggedized, accurate timing such as GPS/GNSS tracking, military radios, medical devices, and satellite com…
Keros Therapeutics reported a net loss of $23.7 million for Q1 2026, a significant decline from net income in Q1 2025, mainly due to the absence of license revenue recognized in the prior year from its agreement with Takeda. R&D expenses declined substantially as Takeda took over elritercept-related development and corporate restructuring costs dec…
MeiraGTx reported Q1 2026 financial and operational results including receipt of FDA Breakthrough Therapy Designation for AAV2-hAQP1, positive long-term data in radiation-induced xerostomia, and acquisition of botaretigene sparoparvovec (bota-vec) from Johnson & Johnson targeting X-linked retinitis pigmentosa. The company strengthened its balance s…
INmune Bio Inc. announced that its drug candidate XPro1595 (pegipanermin), a selective soluble TNF inhibitor targeting neuroinflammation, has received Fast Track designation from the FDA for the treatment of early Alzheimer's disease, including mild cognitive impairment and mild dementia due to Alzheimer’s. This designation supports expedited devel…
Chemomab Therapeutics reported its financial results for Q1 2026 and provided a corporate update focusing on its lead drug candidate nebokitug. The company presented new clinical and translational data from its Phase 2 SPRING trial showing nebokitug’s potential to modulate disease pathways in primary sclerosing cholangitis (PSC) and coexisting infl…
Kyverna Therapeutics, a late-stage clinical biopharmaceutical company specializing in cell therapies for autoimmune diseases, announced presentations at key investor conferences in May and June 2026. Their lead CAR T-cell therapy candidate, miv-cel, shows promise in treating B-cell-driven autoimmune disorders including stiff person syndrome and gen…
Xcel Brands announced a partnership with renowned dog behaviorist Cesar Millan to premiere his new pet product collection, Trust, Respect, Love by Cesar Millan, on QVC starting September 2026. The collection will include high-quality pet essentials inspired by Millan's dog training philosophy and is aimed at enhancing daily routines for dogs and th…
Standard Lithium Ltd., via its partnership Smackover Lithium with Equinor, announced completion of the U.S. Department of Energy's National Environmental Policy Act review with a Finding of No Significant Impact for the South West Arkansas lithium project. This approval removes a major regulatory hurdle, enabling the project to proceed toward a Fin…
Aduro Clean Technologies has joined the Utah Petroleum Association to engage with the oil and gas industry in Utah's Uinta Basin. This strategic membership supports Aduro's efforts to develop and pilot its Hydrochemolytic™ Technology for upgrading waxy paraffinic crude oils, aiming to improve transport and refinery compatibility. Recent bench-scale…
Micware Co., Ltd., a Japan-based software provider focused on automotive and mobility IT solutions, has announced the commencement of trading of its American Depositary Shares (ADSs) on the Nasdaq Global Market under the ticker symbol MWC. The listing marks Micware's entrance into the U.S. capital markets, supported by its strong OEM relationships …
ZenaTech, Inc. announces significant progress on its ZenaDrone 2000 heavy-lift interceptor drone, with manufacturing and system integration completed and initial flight testing scheduled for Q3 2026. The drone targets the growing $20 billion counter-drone defense market, offering gas-powered extended endurance, autonomous threat detection, and mult…
Corbus Pharmaceuticals has appointed Brent Pfeiffenberger, a seasoned pharma executive with extensive leadership roles at Bristol Myers Squibb and Century Therapeutics, to its Board of Directors. His expertise is expected to support Corbus’ ongoing development of its oncology treatment CRB-701 and obesity treatment CRB-913. The company anticipates …
